Immunology and Clinical Manifestations of Non-Clonal Mast Cell Activation Syndrome

被引：34

作者：

Cardet, Juan-Carlos ^{[1
,2
]}

Castells, Mariana C. ^{[1
,2
]}

Hamilton, Matthew J. ^{[2
,3
]}

机构：

[1] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA

来源：

CURRENT ALLERGY AND ASTHMA REPORTS | 2013年 / 13卷 / 01期

关键词：

Mast cell activation; Non-clonal mast cell activation syndrome; Tryptase; Prostaglandin; Histamine; cKIT; Flushing; Anaphylaxis; Antihistamines; Immunology; BLOOD MONONUCLEAR-CELLS; SYSTEMIC MASTOCYTOSIS; TRYPTASE LEVELS; C-KIT; PROSTAGLANDIN D-2; TYROSINE KINASE; SPANISH NETWORK; BONE-MARROW; ANAPHYLAXIS; DISORDERS;

D O I：

10.1007/s11882-012-0326-8

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

There is a spectrum of disorders that clinically manifest as a result of mast cell activation. A non-clonal form has emerged in the literature where many of the clinical features of systemic mastocytosis are shared despite having a distinct mast cell biology. In this review, we summarize key features of the science behind mast cell activation relevant to what is now known as non-clonal mast cell activation syndrome (nc-MCAS). We highlight the clinical manifestations of nc-MCAS with a focus on diagnosis and treatment.

引用

页码：10 / 18

页数：9

共 74 条

[1] Sclerosing mediastinitis and mast cell activation syndrome [J].

Afrin, Lawrence B. .

PATHOLOGY RESEARCH AND PRACTICE, 2012, 208 (03) :181-185

[2] Mast Cell Activation Syndrome Masquerading as Agranulocytosis [J].

Afrin, Lawrence B. .

MILITARY MEDICINE, 2012, 177 (01) :113-117

[3] Polycythemia From Mast Cell Activation Syndrome: Lessons Learned [J].

Afrin, Lawrence B. .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 342 (01) :44-49

[4] Burning mouth syndrome and mast cell activation disorder [J].

Afrin, Lawrence B. .

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2011, 111 (04) :465-472

[5] Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis [J].

Akin, Cem ;

Scott, Linda M. ;

Kocabas, Can N. ;

Kushnir-Sukhov, Nataliya ;

Brittain, Erica ;

Noel, Pierre ;

Metcalfe, Dean D. .

BLOOD, 2007, 110 (07) :2331-2333

[6] Molecular diagnosis of mast cell disorders - A Paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology [J].

Akin, Cem .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (04) :412-419

[7] Mast cell activation syndrome: Proposed diagnostic criteria [J].

Akin, Cem ;

Valent, Peter ;

Metcalfe, Dean D. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (06) :1099-U60

[8] Anaphylaxis and Mast Cell Disease: What Is the Risk? [J].

Akin, Cem .

CURRENT ALLERGY AND ASTHMA REPORTS, 2010, 10 (01) :34-38

[9] Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms [J].

Alvarez-Twose, Ivan ;

Gonzalez de Olano, David ;

Sanchez-Munoz, Laura ;

Matito, Almudena ;

Esteban-Lopez, Maria I. ;

Vega, Arantza ;

Belen Mateo, Maria ;

Alonso Diaz de Durana, Maria D. ;

de la Hoz, Belen ;

del Pozo Gil, Maria D. ;

Caballero, Teresa ;

Rosado, Ana ;

Sanchez Matas, Isabel ;

Teodosio, Cristina ;

Jara-Acevedo, Maria ;

Mollejo, Manuela ;

Garcia-Montero, Andres ;

Orfao, Alberto ;

Escribano, Luis .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (06) :1269-1278

[10] DETECTION OF THE MAJOR URINARY METABOLITE OF PROSTAGLANDIN D-2 IN THE CIRCULATION - DEMONSTRATION OF ELEVATED LEVELS IN PATIENTS WITH DISORDERS OF SYSTEMIC MAST-CELL ACTIVATION [J].

AWAD, JA ;

MORROW, JD ;

ROBERTS, LJ .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (05) :817-824

← 1 2 3 4 5 6 7 8 →